𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease

✍ Scribed by Robert C. Thompson; David J. Dripps; Stephen P. Eisenberg


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
459 KB
Volume
14
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Neuroprotective actions of endogenous in
✍ Emmanuel Pinteaux; Nancy J. Rothwell; Herve Boutin πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 185 KB

## Abstract The pro‐inflammatory cytokine interleukin‐1 (IL‐1), contributes to neuronal inflammation and cell death induced by ischemia, excitotoxicity, or trauma, while administration of IL‐1 receptor antagonist (IL‐1ra) reduces neuronal injury. The aim of the present study was to test the hypothe

A tissue specific IL-1 receptor antagoni
✍ Jenny L. Barton; Ruth Herbst; Daniela Bosisio; Lee Higgins; Martin J. H. Nicklin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 201 KB

Interleukin (IL)-1-like protein 1 (IL-1L1) is a 155-amino acid protein that shares 27% identity with IL-1 g and 47% with IL-1 receptor antagonist (IL-1ra). A 2.7-kb IL-1L1 mRNA was cloned from human placenta and is detectable in the trophoblastic cell line JEG-3, in macrophages and in endotoxin-stim

Characterization of type II intracellula
✍ Marta Muzio; Nadia Polentarutti; Fabio Facchetti; Giuseppe Peri; Andrea Doni; Ma πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

Three molecular forms of the IL-1 receptor antagonist (IL-1ra) have been identified and cloned. Secreted IL-1ra (sIL-1ra or IL-1ra1) contains a classical leader peptide giving a released mature protein. Two intracellular isoforms, icIL-1ra type I (IL-1ra2) and icIL-1ra type II (IL-1ra3), have no lea